阿奇霉素至脏疾病的FDA最新报道.docVIP

  • 6
  • 0
  • 约4.69千字
  • 约 5页
  • 2016-12-07 发布于贵州
  • 举报
阿奇霉素至脏疾病的FDA最新报道

FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms?Safety Announcement [3-12-2013] 牋The U.S. Food and Drug Administration (FDA) is warning the public that azithromycin (Zithromax or Zmax) can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm. Patients at particular risk for developing this condition include those with known risk factors such as existing QT interval prolongation, low blood levels of potassium or magnesium, a slower than normal heart rate, or us

文档评论(0)

1亿VIP精品文档

相关文档